Unique combination OC approved

March 27, 2006

A new monophasic oral contraceptive (OC) from Berlex Inc. may offer women less hormonal fluctuation between monthly cycles than traditional OCs. Yaz contains both 3 mg of drospirenone and 20 mcg ethinyl estradiol in a 24-day active pill regimen-a longer period of time than traditional OCs, which typically provide 21 days of hormone-containing tablets.

Unique combination OC approved

A new monophasic oral contraceptive (OC) from Berlex Inc. may offer women less hormonal fluctuation between monthly cycles than traditional OCs. Yaz contains both 3 mg of drospirenone and 20 mcg ethinyl estradiol in a 24-day active pill regimen-a longer period of time than traditional OCs, which typically provide 21 days of hormone-containing tablets. The progestin drospirenone is a spironolactone analog with antimineralocorticoid properties and is not recommended for use by patients with conditions that predispose them to hyperkalemia. Yaz will be available to pharmacies in April.

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.